Literature DB >> 30451487

Hypoxia-Activated, Small-Molecule-Induced Gene Expression.

Sarah L Collins1,2, Jaideep Saha1, Laure C Bouchez3, Ester M Hammond2, Stuart J Conway1.   

Abstract

Hypoxia, a condition of reduced oxygen, occurs in a wide variety of biological contexts, including solid tumors and bacterial biofilms, which are relevant to human health. Consequently, the development of chemical tools to study hypoxia is vital. Here we report a hypoxia-activated, small-molecule-mediated gene expression system using a bioreductive prodrug of the inducer isopropyl 1-thio-β-d-galactopyranoside. As a proof-of-concept we have placed the production of a green fluorescent protein under the control of hypoxia. Our system has the potential to be extended to regulate the production of any given protein of choice.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30451487     DOI: 10.1021/acschembio.8b00858

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  2 in total

1.  Synthetic methodology towards allylic trans-cyclooctene-ethers enables modification of carbohydrates: bioorthogonal manipulation of the lac repressor.

Authors:  Mark A R de Geus; G J Mirjam Groenewold; Elmer Maurits; Can Araman; Sander I van Kasteren
Journal:  Chem Sci       Date:  2020-09-08       Impact factor: 9.825

2.  Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor.

Authors:  Anna Skwarska; Ewen D D Calder; Deborah Sneddon; Hannah Bolland; Maria L Odyniec; Ishna N Mistry; Jennifer Martin; Lisa K Folkes; Stuart J Conway; Ester M Hammond
Journal:  Cell Chem Biol       Date:  2021-04-27       Impact factor: 8.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.